Filter Results:
(1,243)
Show Results For
- All HBS Web
(1,243)
- People (5)
- News (171)
- Research (928)
- Events (6)
- Multimedia (12)
- Faculty Publications (756)
Show Results For
- All HBS Web
(1,243)
- People (5)
- News (171)
- Research (928)
- Events (6)
- Multimedia (12)
- Faculty Publications (756)
- February 1999 (Revised August 2005)
- Teaching Note
BIOPURE Corporation (TN)
Teaching Note for (9-598-150). View Details
Keywords: Pharmaceutical Industry
- February 1995 (Revised March 1995)
- Teaching Note
Astra/Merck Group TN
By: Frank V. Cespedes
Teaching Note for (9-594-045). View Details
Keywords: Pharmaceutical Industry
- January 1993 (Revised November 1993)
- Case
Warner-Lambert Ireland: Niconil
By: John A. Quelch and Susan Smith
The marketing director of Warner-Lambert's Irish subsidiary is completing the marketing plan for the launch of Niconil, a transdermal skin patch to facilitate smoking cessation. View Details
Quelch, John A., and Susan Smith. "Warner-Lambert Ireland: Niconil." Harvard Business School Case 593-008, January 1993. (Revised November 1993.)
- April 1990 (Revised November 1992)
- Case
Population Services International: The Social Marketing Project in Bangladesh (Abridged)
By: James E. Austin
Population Services International (PSI) was a not-for-profit agency founded to disseminate family planning information and to market birth control products, primarily in less developed countries seeking to curb their population explosions. In 1976, PSI concluded an... View Details
Keywords: Conferences; Developing Countries and Economies; Information Publishing; Growth and Development Strategy; Marketing Strategy; Social Marketing; Agreements and Arrangements; Product; Nonprofit Organizations; Pharmaceutical Industry; Bangladesh; Washington (state, US)
Austin, James E. "Population Services International: The Social Marketing Project in Bangladesh (Abridged)." Harvard Business School Case 590-061, April 1990. (Revised November 1992.)
- April 1978
- Case
FTC and Listerine Antiseptic
Keywords: Business and Government Relations; Misleading and Fraudulent Advertising; Pharmaceutical Industry
Greyser, Stephen A. "FTC and Listerine Antiseptic." Harvard Business School Case 578-166, April 1978.
- February 1973 (Revised June 1973)
- Case
Listerine Antiseptic (A)
Greyser, Stephen A. "Listerine Antiseptic (A)." Harvard Business School Case 573-060, February 1973. (Revised June 1973.)
- September 1990 (Revised November 1991)
- Supplement
Merck & Co., Inc. (C)
Discusses the 1989 modified performance appraisal program by adding performance gradations and allowing for differences in employee rating distributions depending on the division performance for the year. The objective is to have students discuss the revisions in the... View Details
Murphy, Kevin J. "Merck & Co., Inc. (C)." Harvard Business School Supplement 491-007, September 1990. (Revised November 1991.)
- March 1999 (Revised January 2001)
- Case
Hans Fritz at Novartis Thailand (B): The First Six Months
By: Michael Y. Yoshino and Carin-Isabel Knoop
Supplements the (A) case. View Details
Yoshino, Michael Y., and Carin-Isabel Knoop. "Hans Fritz at Novartis Thailand (B): The First Six Months." Harvard Business School Case 399-124, March 1999. (Revised January 2001.)
- November 1978 (Revised January 1983)
- Case
Vick International Division: Tom McGuire
Explores the ways in which International Division management uses formal management systems in carrying out its roles in the management processes of one division of a diversified drug company. View Details
Keywords: Globalized Firms and Management; Business Divisions; Management Systems; Pharmaceutical Industry
Vancil, Richard F. "Vick International Division: Tom McGuire." Harvard Business School Case 179-068, November 1978. (Revised January 1983.)
- August 1989 (Revised October 2005)
- Case
James Burke: A Career in American Business (B)
By: Richard S. Tedlow and Wendy Smith
Covers the history of Tylenol from the autumn of 1982 through the second tampering incident in February 1986. Also deals with other developments in the history of Johnson & Johnson, especially the acquisition and divestiture of Technicare. View Details
Tedlow, Richard S., and Wendy Smith. "James Burke: A Career in American Business (B)." Harvard Business School Case 390-030, August 1989. (Revised October 2005.)
- 25 Jun 2019
- Blog Post
Learning the Language of Business and Science – The MS/MBA Biotechnology: Life Sciences Program
pharmaceutical company. I then chose to go to HBS to get my first formal training in business. This has helped me to become fluent in the language of business, evaluate strategic decisions through a different lens, and grow my network... View Details
- Fast Answer
Investing in Life Sciences - SIP Resources
healthcare, pharmaceuticals and biotech industries including policy and science developments, and overview of different technologies. Factiva - Covers news from national and local newspapers, magazines, trade publications and transcripts... View Details
- 01 Mar 2012
- News
How to Close the Health Gap
real progress has been made over the last decade, thanks in part to funding from organizations such as the Bill & Melinda Gates Foundation and efforts by pharmaceutical companies and governments to make drugs available at little or no... View Details
- 06 May 2008
- First Look
First Look: May 6, 2008
company which had been put up for sale by pharmaceutical giant Pfizer. Examining the decision from a strategic perspective, the (A) case provides brief histories of the two companies; traces the global confectionery industry, focusing... View Details
Keywords: Martha Lagace
- 09 Feb 2018
- Working Paper Summaries
Developing Novel Drugs
- 24 Jul 2014
- Op-Ed
Reform Tax Law to Keep US Firms at Home
Editor's Note. Given a veritable flood over the last year of corporate "inversions"—US companies that reincoporate in other countries to take advantage of favorable tax rates and business regulations—lawmakers in Washington D.C. are debating how to respond.... View Details
- 23 Aug 2020
- News
In the UK, She Leads the Search for a COVID Vaccine
told the Daily Mail. In fact, Bingham’s role—working with pharmaceutical firms, planning manufacturing facilities, and making investment decisions—ties in directly with her career experience. “As a venture capitalist, I have to write a... View Details
- Profile
Paul Wang
work with the MIT’s Abdul Latif Jameel Poverty Action Lab (J-PAL). “They’re a group of economists who use randomized evaluation methodologies, similar to those used in pharmaceutical trials, to assess the impact of development projects,”... View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
coming of age of biotechnology. The disappearance of "blockbuster" drugs could create new management challenges for pharmaceutical companies. — Gary Pisano The prospect is exhilarating, but the road to this brave new biotech... View Details